ERIC DELENTE P r esiden t , P a tien t Solutions D r ugDe v C o n tr ib ut ed b y D r ug D e v is c om m it te d to pr ovidin g spo nso rs , C RO s , and sit es with so l utio ns that tr ansf o rm c linic al r esear c h thr o ugh c o l l ab o r atio n, stand ar d izatio n, and a b ea utiful t echnolog y e xp er ienc e . F or mor e inf or ma tion, visit d r ugde v .c om. I Retaining the Patients The result of all this is a system that is flexible, easy-to-understand, and ensures each patient finishes the consent process informed and with all questions answered. This is crit- ical, as patients who truly understand what they’re consenting to, are more likely to finish the trial. A 2003 CenterWatch report measured the enrollment rates of two identical trials — one using eConsent and o

Join for free to read